VCRE
Vicore Pharma Holding AB • NASDAQ
$12.38 ▼ -0.08% (-0.01)
VCRE
Vicore Pharma Holding ABNASDAQ • $12.38 ▼ -0.08% (-0.01)
Market Cap $3.36 B
52w High $17.80
52w Low $11.05
P/E 0
Volume 4.03K
Outstanding Shares 281.53M
Market Cap $3.36 B
52w High $17.80
52w Low $11.05
P/E 0
Volume 4.03K
Outstanding Shares 281.53M
About Vicore Pharma Holding AB
https://vicorepharma.comVicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.
CEO
Ahmed Mousa
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Medical - Pharmaceuticals
Sector Healthcare
Went public July 2, 2026
Method of going public Dual Listing
Full time employees 40
AUG
21 FRI
Upcoming Earnings
Date Aug 21, 2026
Day Friday
Revenue Est. $55,047
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0